
  
    
      
        Background_NNP
        Prostaglandin_NNP E_NNP 
        2_CD is_VBZ a_DT major_JJ cyclooxygenase_NN metabolite_NN
        of_IN arachidonic_JJ acid_NN which_WDT exerts_NNS diverse_JJ effects_NNS on_IN
        vascular_NN smooth_JJ muscle_NN tone_NN and_CC epithelial_NN solute_NN transport_NN
        via_IN G-_NNP protein_NN coupled_VBN receptors_NNS [_NN 1_CD 2_CD ]_NN ._. At_IN least_JJS four_CD
        distinct_JJ G-_NNP protein_NN coupled_VBN PGE_NNP 
        2_CD receptors_NNS have_VBP been_VBN cloned_VBN :_: the_DT EP_NNP 
        1_CD ,_, EP_NNP 
        2_CD ,_, EP_NNP 
        3_CD ,_, and_CC EP_NNP 
        4_CD [_NN 1_CD ]_NN ._. Pharmacological_NNP studies_NNS
        suggest_VBP PGE_NNP 
        2_CD relaxes_NNS vascular_NN smooth_JJ muscle_NN through_IN
        two_CD of_IN these_DT receptors_NNS ,_, the_DT EP_NNP 
        2_CD and_CC EP_NNP 
        4_CD receptors_NNS ,_, which_WDT couple_NN to_TO cyclic-_NN AMP_NNP
        generation_NN [_NN 3_CD ]_NN ._. In_IN contrast_NN ,_, PGE_NNP 
        2_CD constricts_NNS other_JJ vascular_NN smooth_JJ
        muscle_NN through_IN EP_NNP 
        3_CD receptors_NNS which_WDT inhibit_VBP cAMP_NN
        generation_NN via_IN G_NNP 
        i_NNP or_CC EP_NNP 
        1_CD receptors_NNS which_WDT increase_VBP Ca_MD
        2_CD +_NN mobilization_NN [_NN 3_CD ]_NN ._. Although_IN both_DT EP_NNP 
        2_CD and_CC EP_NNP 
        4_CD receptors_NNS relax_VBP smooth_JJ muscle_NN ,_, EP_NNP 
        2_CD receptors_NNS are_VBP uniquely_RB sensitive_JJ to_TO
        the_DT agonists_NNS butaprost_NN and_CC AH_NNP 13205_CD [_NN 3_CD 4_CD ]_NN ._. Previous_JJ
        studies_NNS have_VBP shown_VBN that_IN PGE_NNP 
        2_CD increases_NNS the_DT cAMP_NN concentration_NN in_IN
        many_JJ tissues_NNS including_VBG kidney_NN ,_, intestine_NN and_CC uterus_NN ,_, but_CC
        the_DT relative_JJ contribution_NN of_IN EP_NNP 
        2_CD versus_CC EP_NNP 
        4_CD receptors_NNS to_TO these_DT effects_NNS is_VBZ
        incompletely_RB defined_VBN [_NN 5_CD 6_CD ]_NN ._. Recent_JJ studies_NNS in_IN mice_NNS with_IN
        targeted_VBN disruption_NN of_IN these_DT receptors_NNS have_VBP suggested_VBN an_DT
        important_JJ role_NN for_IN EP_NNP 2_CD receptor_NN in_IN regulating_VBG systemic_JJ
        hemodynamics_NNS ._. Deficiency_NNP of_IN the_DT EP_NNP 2_CD receptor_NN is_VBZ associated_VBN
        with_IN a_DT defect_NN in_IN counteracting_VBG vasopressor_NN effect_NN of_IN PGE_NNP 2_CD [_NN
        7_CD ]_NN and_CC the_DT development_NN of_IN salt_NN sensitive_JJ hypertension_NN [_NN 8_CD
        ]_NN ,_, suggesting_VBG a_DT predominant_NN normal_JJ vasodepressor_NN role_NN of_IN
        EP_NNP 2_CD receptor_NN in_IN blood_NN pressure_NN regulation_NN ._.
        The_DT vasodepressor_NN action_NN of_IN PGE_NNP 2_CD may_MD also_RB play_VB an_DT
        important_JJ role_NN in_IN the_DT kidney_NN ._. It_PRP has_VBZ been_VBN previously_RB shown_VBN
        that_IN PGE_NNP 2_CD not_RB only_RB directly_RB dilates_NNS renal_JJ arteries_NNS [_NN 9_CD 10_CD
        11_CD ]_NN but_CC also_RB attenuates_NNS the_DT AngII-induced_NNP increase_NN in_IN
        renal_JJ vascular_NN resistance_NN [_NN 12_CD ]_NN through_IN inhibition_NN of_IN
        AngII-elicited_NNP intracellular_NN Ca_MD +_NN +_NN increase_NN in_IN vascular_NN
        smooth_JJ muscle_NN cells_NNS of_IN preglomerular_NN vasculature_NN [_NN 13_CD ]_NN ._.
        Based_VBN on_IN the_DT fact_NN that_IN PGE_NNP 2_CD stimulates_NNS cAMP_NN generation_NN in_IN
        freshly_RB isolated_VBN preglomerular_NN renal_JJ arterioles_NNS [_NN 14_CD ]_NN ,_,
        the_DT cAMP-stimulating_JJ EP_NNP 2_CD or_CC EP_NNP 4_CD receptor_NN has_VBZ been_VBN thought_VBN
        to_TO mediate_VB these_DT effects_NNS of_IN PGE_NNP 2_CD on_IN renal_JJ resistance_NN
        vessels_NNS ._.
        There_EX is_VBZ also_RB evidence_NN suggesting_VBG that_DT intrarenal_NN EP_NNP 2_CD
        and_CC EP_NNP 4_CD receptor_NN activates_NNS cAMP-stimulated_JJ salt_NN and_CC water_NN
        transport_NN along_IN the_DT nephron_NN [_NN 15_CD 16_CD 17_CD 18_CD ]_NN ._. Although_IN the_DT
        localization_NN of_IN EP_NNP 1_CD ,_, EP_NNP 3_CD and_CC EP_NNP 4_CD has_VBZ been_VBN determined_VBN in_IN
        human_JJ kidney_NN by_IN in_IN situ_NN hybridization_NN ,_, segmental_NN
        distribution_NN of_IN cAMP-coupled_JJ EP_NNP 2_CD receptor_NN along_IN the_DT nephron_NN
        was_VBD not_RB detected_VBN by_IN this_DT method_NN [_NN 19_CD ]_NN ._. To_TO more_RBR clearly_RB
        define_VB the_DT physiologic_JJ role_NN of_IN this_DT cAMP_NN coupled_VBN EP_NNP
        receptor_NN ,_, we_PRP cloned_VBN the_DT rabbit_NN EP_NNP 
        2_CD receptor_NN ,_, characterized_VBD its_PRP$
        pharmacology_NN and_CC signaling_VBG ._. These_DT studies_NNS also_RB defined_VBD the_DT
        tissue_NN distribution_NN with_IN a_DT focus_NN on_IN vascular_NN ,_, intrarenal_NN
        and_CC reproductive_JJ localization_NN of_IN the_DT rabbit_NN EP_NNP 2_CD receptor_NN
        mRNA_NN ._.
      
      
        Results_NNS
        
          Receptor_NNP isolation_NN
          Screening_NNP of_IN 5_CD Ã—_NN 10_CD 5_CD plaques_NNS from_IN a_DT rabbit_NN genomic_JJ
          library_NN using_VBG a_DT full-length_JJ human_JJ cDNA_NN for_IN the_DT EP_NNP 
          2_CD receptor_NN resulted_VBD in_IN isolation_NN of_IN
          two_CD independent_JJ clones_NNS designated_VBN 4_CD B_NNP 1_CD (_( 13_CD kb_NN )_) and_CC 6_CD A_DT (_( 11_CD
          kb_NN )_) ._. A_DT 5_CD '_POS coding_VBG exon_NN of_IN EP_NNP 
          2_CD receptor_NN was_VBD contained_VBN in_IN clone_NN 4_CD B_NNP 1_CD ,_,
          while_IN a_DT 3_CD '_POS coding_VBG exon_NN was_VBD contained_VBN in_IN clone_NN 6_CD A_DT ._.
          Sequence_NNP data_NNS indicated_VBD that_IN the_DT entire_JJ coding_VBG region_NN was_VBD
          present_JJ in_IN these_DT two_CD exons_NNS ._. A_DT potential_JJ translation_NN
          initiation_NN codon_NN in_IN the_DT NotI_NNP /_NN BamHI_NNP fragment_NN (_( 3_CD kb_NN )_) of_IN
          clone_NN 4_CD B_NNP 1_CD starts_VBZ an_DT open_JJ reading_NN frame_NN that_IN encodes_NNS a_DT
          polypeptide_NN sequence_NN highly_RB homologous_RB to_TO the_DT first_JJ six_CD
          transmembrane_NN domains_NNS of_IN the_DT human_JJ EP_NNP 2_CD receptor_NN [_NN 20_CD ]_NN ._.
          The_DT amino_JJ acid_NN sequence_NN of_IN the_DT open_JJ reading_NN frame_NN in_IN the_DT
          NotI_NNP fragment_NN (_( 6_CD kb_NN )_) of_IN clone_NN 6_CD A_DT was_VBD homologous_RB to_TO the_DT
          seventh_JJ transmembrane_NN domain_NN (_( TMD_NNP VII_NNP )_) ,_, followed_VBN by_IN a_DT
          short_JJ C-_NNP terminal_NN tail_NN and_CC an_DT in-frame_JJ stop_NN codon_NN ._. An_DT
          intron_NN with_IN a_DT donor_NN and_CC acceptor_NN splice_NN site_NN was_VBD located_VBN
          following_VBG the_DT coding_VBG region_NN corresponding_JJ to_TO the_DT sixth_JJ
          transmembrane_NN domain_NN of_IN the_DT protein_NN ._.
          A_DT functional_JJ cDNA_NN clone_NN was_VBD obtained_VBN by_IN screening_VBG a_DT
          rabbit_NN uterus_NN cDNA_NN library_NN using_VBG a_DT 700_CD bp_NN AvaII_NNP cDNA_NN
          fragment_NN from_IN clone_NN 4_CD B_NNP 1_CD ._. Two_CD types_NNS of_IN positive_JJ
          overlapping_VBG clones_NNS (_( 18_CD A_DT and_CC REP_NNP 
          2_CD -_: 2_CD ._. 7_CD )_) were_VBD isolated_VBN ._. Of_IN the_DT 18_CD
          positive_JJ cDNA_NN clones_NNS isolated_VBN ,_, 8_CD belonged_VBD to_TO the_DT type_NN
          designated_VBN REP_NNP 
          2_CD -_: 18_CD A_DT ,_, and_CC 10_CD clones_NNS belonged_VBD to_TO the_DT
          type_NN designated_VBN REP_NNP 2_CD -_: 2_CD ._. 7_CD ._. Sequence_NNP analysis_NN indicated_VBD
          that_IN these_DT two_CD cDNAs_NNS possess_VBP an_DT identical_JJ open_JJ reading_NN
          frame_NN and_CC 1_CD ,_, 664_CD bp_NN of_IN down-stream_JJ 3_CD '_POS untranslated_JJ region_NN
          (_( 3_CD '_POS UTR_NNP )_) ,_, however_RB clone_NN REP_NNP 
          2_CD -_: 18_CD A_DT possesses_VBZ an_DT 467_CD additional_JJ
          base_NN pairs_NNS in_IN the_DT 3_CD '_POS UTR_NNP compared_VBD with_IN REP_NNP 2_CD -_: 2_CD ._. 7_CD ._. It_PRP is_VBZ
          also_RB noted_VBN that_IN there_EX are_VBP 6_CD and_CC 7_CD AUUUA_NNP motifs_NNS in_IN 3_CD '_POS UTR_NNP
          of_IN REP_NNP 2_CD -_: 2_CD ._. 7_CD and_CC REP_NNP 2_CD -_: 18_CD A_DT ,_, respectively_RB ,_, suggesting_VBG an_DT
          instability_NN of_IN rabbit_NN EP_NNP 2_CD receptor_NN mRNA_NN in_IN vivo_NN ._.
          Because_IN both_DT rabbit_NN EP_NNP 2_CD cDNA_NN clones_NNS ,_, 18_CD A_DT and_CC REP_NNP 
          2_CD -_: 2_CD ._. 7_CD ,_, lacked_VBD ~_NN 50_CD codons_NNS
          corresponding_JJ to_TO the_DT 5_CD '_POS end_NN of_IN the_DT human_JJ EP_NNP 2_CD receptor_NN and_CC
          which_WDT were_VBD present_JJ in_IN the_DT rabbit_NN genomic_JJ sequence_NN ,_, a_DT
          full-length_JJ sequence_NN of_IN the_DT rabbit_NN EP_NNP 
          2_CD was_VBD constructed_VBN by_IN ligating_VBG a_DT
          SacII_NNP /_NN XhoI_NNP cDNA_NN fragment_NN (_( nucleotide_NN 340_CD -_: 1655_CD )_) from_IN the_DT
          cDNA_NN clone_NN 18_CD A_DT with_IN the_DT upstream_RB Hind_NNP III_NNP /_NN SacII_NNP fragment_NN
          (_( nucleotide_NN 1_CD -_: 340_CD )_) of_IN the_DT rabbit_NN genomic_JJ clone_NN ._. This_DT
          created_VBD an_DT open_JJ reading_NN frame_NN of_IN 1_CD ,_, 083_CD base_NN pairs_NNS with_IN an_DT
          in-frame_JJ TGA_NNP stop_VB codon_NN ._. The_DT existence_NN of_IN this_DT 5_CD '_POS UTR_NNP
          sequence_NN in_IN native_JJ cDNA_NN was_VBD confirmed_VBN by_IN RT-PCR_NNP on_IN RNA_NNP
          isolated_VBD from_IN rabbit_NN uterus_NN (_( data_NNS not_RB shown_VBN )_) ._. The_DT
          predicted_VBN polypeptide_NN is_VBZ comprised_VBN of_IN 361_CD amino_JJ acids_NNS
          with_IN a_DT calculated_VBN molecular_JJ weight_NN of_IN ~_NN 40_CD kDa_NN ._. Its_PRP$
          hydrophobic_JJ profile_NN reveals_VBZ the_DT presence_NN of_IN seven_CD
          hydrophobic_JJ stretches_VBZ characteristic_NN of_IN G-_NNP protein-coupled_JJ
          receptors_NNS [_NN 20_CD ]_NN (_( Fig_NNP ._. 1_LS )_) ._. Comparison_NNP of_IN the_DT deduced_JJ
          amino_JJ acid_NN sequence_NN of_IN rabbit_NN EP_NNP 
          2_CD with_IN human_NN and_CC mouse_NN EP_NNP 
          2_CD shows_VBZ 90_CD %_NN and_CC 82_CD %_NN sequence_NN identity_NN ,_,
          respectively_RB (_( Fig_NNP ._. 1_LS )_) ._.
        
        
          Ligand_NNP binding_JJ properties_NNS of_IN the_DT EP_NNP
          2_CD receptor_NN
          The_DT putative_JJ rabbit_NN EP_NNP 
          2_CD receptor_NN was_VBD pharmacologically_RB
          characterized_VBN using_VBG membranes_NNS from_IN COS-_NNP 1_CD cells_NNS
          transiently_RB transfected_JJ with_IN a_DT rabbit_NN EP_NNP 2_CD expression_NN
          vector_NN ,_, pcDNA_NN 3_CD /_NN REP_NNP 
          2_CD ._. Membranes_NNP from_IN EP_NNP 
          2_CD receptor_NN transfected_JJ COS-_NNP 1_CD cells_NNS ,_,
          exhibited_VBN saturable_JJ [_NN 3_CD H_NNP ]_NN PGE_NNP 
          2_CD binding_VBG with_IN a_DT dissociation_NN constant_JJ
          of_IN 19_CD ._. 1_LS Â±_NN 1_CD ._. 7_CD nM_NN ,_, and_CC a_DT maximum_NN binding_JJ capacity_NN (_( B_NNP 
          max_NN )_) of_IN 2_CD ._. 8_CD pmol_NN /_NN mg_NN of_IN membrane_NN
          protein_NN ._. Radioligand_NNP binding_JJ studies_NNS were_VBD performed_VBN using_VBG
          various_JJ prostanoids_NNS and_CC EP-receptor_NNP subtype-specific_JJ
          agonists_NNS to_TO compete_VB for_IN PGE_NNP 2_CD binding_JJ ._. Competition_NN binding_JJ
          experiments_NNS revealed_VBD a_DT rank_NN order_NN affinity_NN consistent_JJ
          with_IN an_DT EP_NNP receptor_NN :_: PGE_NNP 
          2_CD >_NN >_NN iloprost_NN =_SYM PGD_NNP 
          2_CD =_SYM PGF_NNP 
          2_CD Î±_NN (_( Fig_NNP ._. 2_LS A_DT )_) ._. [_NN 3_CD H_NNP ]_NN PGE_NNP 
          2_CD binding_JJ was_VBD partially_RB displaced_VBN by_IN
          the_DT EP_NNP 
          2_CD /_NN 3_CD /_NN 4_CD agonist_NN misoprostol_NN and_CC was_VBD not_RB
          displaced_VBN by_IN the_DT EP_NNP 
          1_CD /_NN 3_CD agonist_NN sulprostone_NN (_( Fig_NNP ._. 2_LS B_NNP )_) ._.
          Furthermore_RB ,_, the_DT EP_NNP 
          2_CD selective_JJ agonists_NNS butaprost_NN free_JJ
          acid_NN and_CC AH_NNP 13205_CD competed_VBN for_IN [_NN 3_CD H_NNP ]_NN PGE_NNP 
          2_CD binding_JJ with_IN K_NNP 
          i_NNP values_NNS of_IN 3_CD -_: 7_CD Î¼M_NN and_CC 3_CD -_: 4_CD Î¼M_NN ,_,
          respectively_RB ,_, suggesting_VBG this_DT receptor_NN is_VBZ the_DT rabbit_NN EP_NNP 
          2_CD receptor_NN [_NN 20_CD 21_CD ]_NN ._.
        
        
          Signal_NNP transduction_NN properties_NNS of_IN the_DT EP_NNP
          2_CD receptor_NN
          Incubation_NNP of_IN EP_NNP 
          2_CD -_: transfected_JJ COS_NNP 1_CD cells_NNS with_IN
          butaprost_NN free_JJ acid_NN produced_VBD a_DT concentration-dependent_JJ
          increase_NN in_IN cAMP_NN accumulation_NN with_IN an_DT EC_NNP 
          50_CD of_IN 480_CD nM_NN (_( Fig_NNP ._. 3_LS )_) ._. Cells_NNP
          transfected_JJ with_IN the_DT vector_NN alone_RB demonstrated_VBD no_DT
          significant_JJ increase_NN in_IN cAMP_NN in_IN response_NN to_TO butaprost_NN
          free_JJ acid_NN ._.
        
        
          Tissue_NNP distribution_NN of_IN the_DT rabbit_NN EP_NNP
          2_CD receptor_NN
          Solution_NN hybridization_NN /_NN RNase_NNP protection_NN assays_NNS with_IN a_DT
          radiolabeled_JJ antisense_NN EP_NNP 
          2_CD riboprobe_NN resulted_VBD in_IN a_DT
          RNase-resistant_NNP fragment_NN of_IN the_DT appropriate_JJ size_NN (_( 322_CD bp_NN ,_,
          Fig_NNP ._. 4_LS )_) ._. EP_NNP 
          2_CD receptor_NN mRNA_NN was_VBD detected_VBN in_IN
          several_JJ tissues_NNS including_VBG ileum_NN ,_, spleen_NN ,_, and_CC liver_NN ._. Lower_JJR
          expression_NN was_VBD found_VBN in_IN kidney_NN ,_, uterus_NN ,_, lung_NN ,_, heart_NN ,_,
          liver_NN ,_, adrenal_NN gland_NN ,_, brain_NN ,_, urinary_JJ bladder_NN and_CC skeletal_NN
          muscle_NN ._. Furthermore_RB ,_, EP_NNP 
          2_CD receptor_NN mRNA_NN was_VBD detected_VBN by_IN RNase_NNP
          protection_NN assay_NN in_IN all_DT blood_NN vessels_NNS examined_VBD (_( Fig_NNP ._. 5_LS )_)
          including_VBG arteries_NNS and_CC veins_NNS of_IN large_JJ and_CC small_JJ caliber_NN
          (_( Fig_NNP ._. 5_LS A_DT &_CC 5_CD C_NNP )_) ,_, and_CC renal_JJ preglomerular_NN vasculature_NN
          (_( Fig_NNP ._. 5_LS B_NNP )_) ._. The_DT expression_NN level_NN of_IN the_DT EP_NNP 
          2_CD receptor_NN mRNA_NN in_IN these_DT vessels_NNS was_VBD
          comparable_JJ to_TO that_DT of_IN the_DT EP_NNP 
          4_CD receptor_NN (_( Fig_NNP ._. 5_LS )_) ._. EP_NNP 
          2_CD receptor_NN mRNA_NN was_VBD also_RB detected_VBN in_IN
          vascular_NN smooth_JJ muscle_NN cells_NNS cultured_JJ from_IN rabbit_NN aorta_NN
          (_( Fig_NNP ._. 6_CD A_DT )_) ._.
        
        
          Intrarenal_NNP localization_NN of_IN the_DT rabbit_NN EP_NNP 2_CD
          receptor_NN
          
          In_IN situ_NN hybridization_NN was_VBD performed_VBN
          to_TO examine_VB the_DT distribution_NN of_IN the_DT EP_NNP 
          2_CD receptor_NN gene_NN expression_NN in_IN the_DT
          kidney_NN and_CC uterus_NN ._. Sections_NNP of_IN rabbit_NN renal_JJ and_CC uterine_NN
          tissues_NNS were_VBD hybridized_JJ with_IN the_DT [_NN 35_CD S_NNP ]_NN -_: labeled_VBN riboprobe_NN
          from_IN the_DT same_JJ cDNA_NN probe_NN used_VBN in_IN RNase-protection_NNP assays_NNS ._.
          As_IN observed_VBD for_IN the_DT mouse_NN EP_NNP 
          2_CD in_IN the_DT uterus_NN ,_, a_DT significant_JJ
          hybridization_NN signal_NN was_VBD detected_VBN mainly_RB in_IN the_DT
          endometrial_NN epithelium_NN of_IN the_DT rabbit_NN uterus_NN with_IN less_JJR
          expression_NN in_IN myometrium_NN (_( Fig_NNP ._. 7_CD )_) ._. Consistent_NNP with_IN
          previous_JJ observation_NN in_IN man_NN [_NN 19_CD ]_NN ,_, only_RB a_DT diffuse_NN weak_JJ
          EP_NNP 2_CD mRNA_NN signal_NN was_VBD detected_VBN in_IN the_DT rabbit_NN kidney_NN (_( Figure_NN
          7_CD )_) ._. To_TO further_VB elucidate_NN the_DT distribution_NN of_IN EP_NNP 2_CD receptor_NN
          along_IN the_DT nephron_NN ,_, nephron_NN segments_NNS were_VBD dissected_VBN and_CC
          expression_NN of_IN EP_NNP 2_CD was_VBD determined_VBN using_VBG RT-PCR_NNP ._. As_IN shown_VBN
          in_IN figure_NN 8_CD ,_, PCR_NNP products_NNS with_IN expected_VBN sizes_NNS were_VBD
          obtained_VBN for_IN both_DT EP_NNP 2_CD receptor_NN (_( 336_CD bp_NN )_) and_CC GAPDH_NNP (_( 411_CD
          bp_NN )_) ._. Identity_NNP of_IN the_DT amplified_VBN products_NNS was_VBD confirmed_VBN by_IN
          Southern_NNP hybridization_NN (_( not_RB shown_VBN )_) and_CC sequencing_VBG ._. As_IN
          positive_JJ control_NN ,_, RT-PCR_NNP was_VBD performed_VBN using_VBG 1_CD Î¼g_NN of_IN
          total_JJ RNA_NNP isolated_VBD from_IN rabbit_NN spleen_NN (_( figure_NN 8_CD )_) ._. As_IN
          negative_JJ control_NN ,_, PCR_NNP were_VBD also_RB performed_VBN in_IN the_DT absence_NN
          of_IN reverse_NN transcription_NN without_IN identifiable_JJ product_NN ,_,
          indicating_VBG the_DT origination_NN of_IN PCR_NNP products_NNS were_VBD from_IN mRNA_NN
          other_JJ than_IN genomic_JJ DNA_NNP (_( figure_NN 8_CD )_) ._. EP_NNP 2_CD receptor_NN mRNA_NN was_VBD
          easily_RB detected_VBN in_IN glomeruli_NN and_CC medullary_JJ collecting_NN
          ducts_NNS (_( MCD_NNP )_) ._. Detectable_NNP EP_NNP 2_CD mRNA_NN was_VBD also_RB present_JJ in_IN thin_JJ
          descending_VBG limbs_NNS of_IN Henle_NNP (_( tDL_NN )_) and_CC cortical_JJ collecting_NN
          ducts_NNS (_( CCD_NNP )_) ._.
          In_IN cultured_JJ cells_NNS RNase_NNP protection_NN assay_NN detected_VBD EP_NNP 2_CD
          expression_NN in_IN renal_JJ medullary_JJ interstitial_NN cells_NNS (_( MICs_NNP )_) ,_,
          while_IN no_DT signal_NN was_VBD detected_VBN in_IN cultured_JJ cortical_JJ
          collecting_NN ducts_NNS or_CC glomerular_NN mesangial_NN cells_NNS (_( Fig_NNP ._.
          6_CD B_NNP &_CC 6_CD C_NNP )_) ._. EP_NNP 2_CD mRNA_NN was_VBD also_RB detected_VBN in_IN cultured_JJ
          rabbit_NN aortic_JJ vascular_NN smooth_JJ muscle_NN cells_NNS (_( Figure_NN
          6_CD A_DT )_) ._.
        
      
      
        Discussion_NNP
        The_DT present_JJ studies_NNS describe_VBP the_DT cloning_VBG and_CC
        characterization_NN of_IN the_DT rabbit_NN EP_NNP 
        2_CD receptor_NN ._. With_IN this_DT information_NN ,_, cDNA_NN
        sequence_NN for_IN all_DT four_CD rabbit_NN EP_NNP receptors_NNS is_VBZ now_RB available_JJ
        [_NN 22_CD 23_CD 24_CD ]_NN ._. Several_JJ similarities_NNS between_IN the_DT rabbit_NN and_CC
        mouse_NN EP_NNP 
        2_CD receptors_NNS exist_VBP [_NN 5_CD 21_CD ]_NN ._. The_DT rabbit_NN
        EP_NNP 
        2_CD genomic_JJ clone_NN contains_VBZ an_DT intron_NN with_IN
        consensus_NN splice_NN donor_NN and_CC acceptor_NN sites_NNS near_IN the_DT end_NN of_IN
        transmembrane_NN domain_NN (_( TM_NNP )_) VI_NNP ._. The_DT relative_JJ position_NN of_IN the_DT
        intron_NN to_TO the_DT coding_VBG regions_NNS is_VBZ also_RB identical_JJ to_TO that_DT
        found_VBD in_IN the_DT human_JJ TP_NNP ,_, the_DT human_NN and_CC mouse_NN DP_NNP ,_, and_CC the_DT
        human_JJ EP_NNP 
        1_CD gene_NN [_NN 2_CD ]_NN ._. This_DT provides_VBZ further_JJ
        evidence_NN that_IN the_DT prostanoid_NN receptor_NN family_NN arose_VBD from_IN a_DT
        common_JJ ancestral_JJ gene_NN ._. The_DT rabbit_NN EP_NNP 
        2_CD gene_NN contains_VBZ a_DT 1_CD ,_, 083_CD bp_NN open_JJ reading_NN
        frame_NN coding_VBG for_IN a_DT 361_CD amino_JJ acid_NN polypeptide_NN ,_, with_IN a_DT
        calculated_VBN molecular_JJ weight_NN of_IN 39_CD ,_, 919_CD Daltons_NNP ._. Its_PRP$ amino_JJ
        acid_NN profile_NN reveals_VBZ the_DT presence_NN of_IN seven_CD hydrophobic_JJ
        regions_NNS which_WDT likely_JJ represent_VB transmembrane_NN domains_NNS ._.
        Unlike_IN the_DT TP_NNP and_CC EP_NNP 
        3_CD receptors_NNS ,_, no_DT alternative_NN splicing_VBG in_IN
        the_DT EP_NNP 
        2_CD receptor_NN was_VBD found_VBN in_IN the_DT coding_VBG
        region_NN [_NN 21_CD 25_CD ]_NN ._. Diversity_NNP of_IN EP_NNP 
        2_CD mRNAs_NNS in_IN the_DT mouse_NN was_VBD found_VBN in_IN both_DT
        the_DT 5_CD '_POS UTR_NNP and_CC the_DT 3_CD '_POS UTR_NNP [_NN 21_CD ]_NN ._. Similar_JJ diversity_NN in_IN the_DT
        3_CD '_POS sequence_NN of_IN the_DT rabbit_NN EP_NNP 
        2_CD receptor_NN cDNA_NN clones_NNS isolated_VBN from_IN the_DT
        uterine_NN library_NN was_VBD observed_VBN in_IN the_DT present_JJ studies_NNS ._. The_DT
        significance_NN of_IN this_DT mRNA_NN splicing_VBG is_VBZ not_RB yet_RB known_VBN ,_, but_CC it_PRP
        might_MD play_VB a_DT role_NN in_IN stability_NN or_CC translation_NN efficiency_NN of_IN
        EP_NNP 
        2_CD transcripts_NNS [_NN 21_CD ]_NN ._.
        Ligand_NNP binding_JJ studies_NNS confirm_VBP that_IN the_DT rabbit_NN EP_NNP 2_CD
        receptor_NN preferentially_RB binds_NNS PGE_NNP 
        2_CD with_IN significantly_RB higher_JJR affinity_NN
        than_IN other_JJ endogenous_JJ prostanoids_NNS ._. Its_PRP$ low_JJ affinity_NN for_IN PGD_NNP
        
        2_LS ,_, PGF_NNP 
        2_CD Î±_NN ,_, iloprost_NN ,_, misoprostol_NN and_CC
        sulprostone_NN suggest_VBP it_PRP is_VBZ not_RB an_DT EP_NNP 
        1_CD ,_, EP_NNP 
        3_CD or_CC IP_NNP receptor_NN [_NN 2_CD 3_CD ]_NN ._. As_IN
        demonstrated_VBN for_IN the_DT EP_NNP 
        2_CD receptor_NN in_IN other_JJ species_NNS [_NN 6_CD 20_CD 21_CD ]_NN
        ,_, butaprost_NN free_JJ acid_NN and_CC AH_NNP 13205_CD ,_, two_CD synthetic_JJ PG_NNP
        agonists_NNS with_IN selectivity_NN for_IN the_DT EP_NNP 
        2_CD subtype_NN ,_, efficiently_RB and_CC dose_NN
        dependently_RB compete_VB for_IN [_NN 3_CD H_NNP ]_NN PGE_NNP 
        2_CD binding_VBG to_TO this_DT newly_RB cloned_VBN rabbit_NN
        receptor_NN ._. Inhibition_NNP of_IN PGE_NNP 
        2_CD binding_VBG to_TO the_DT rabbit_NN EP_NNP 
        2_CD receptor_NN by_IN AH_NNP 13205_CD is_VBZ about_IN 100_CD times_NNS
        greater_JJR than_IN that_DT to_TO rabbit_NN EP_NNP 
        4_CD in_IN transfected_JJ COS-_NNP 1_CD cells_NNS
        (_( unpublished_JJ data_NNS )_) ._. Finally_RB ,_, the_DT EP_NNP 
        2_CD selective_JJ agonist_NN butaprost_NN free_JJ acid_NN
        dose-dependently_JJ stimulated_VBN cAMP_NN generation_NN in_IN COS-_NNP 1_CD cells_NNS
        transfected_JJ with_IN the_DT rabbit_NN EP_NNP 
        2_CD receptor_NN ._. These_DT results_NNS are_VBP in_IN
        agreement_NN with_IN observations_NNS with_IN human_JJ ,_, rat_NN and_CC mouse_NN EP_NNP 2_CD
        receptors_NNS [_NN 6_CD 20_CD 21_CD ]_NN ,_, which_WDT also_RB couple_NN to_TO cAMP_NN
        generation_NN ._. Taken_VBN together_RB ,_, these_DT results_NNS clearly_RB
        demonstrate_VBP that_IN the_DT pharmacology_NN of_IN this_DT receptor_NN
        corresponds_NNS to_TO an_DT EP_NNP 
        2_CD receptor_NN rather_RB than_IN an_DT EP_NNP 
        4_CD receptor_NN ._.
        The_DT expression_NN level_NN of_IN rabbit_NN EP_NNP 2_CD receptor_NN mRNA_NN is_VBZ
        relatively_RB low_JJ ._. Nuclease_NNP protection_NN analysis_NN demonstrated_VBD
        rabbit_NN EP_NNP 
        2_CD expression_NN is_VBZ highest_JJS in_IN ileum_NN ,_, liver_NN ,_,
        and_CC spleen_NN ,_, with_IN a_DT lower_JJR expression_NN in_IN kidney_NN ,_, uterus_NN ,_,
        brain_NN ,_, adrenal_NN gland_NN ,_, lung_NN ,_, heart_NN ,_, bladder_NN ,_, stomach_NN and_CC
        skeletal_NN muscle_NN ._. This_DT mRNA_NN expression_NN pattern_NN is_VBZ similar_JJ to_TO
        that_DT of_IN the_DT EP_NNP 
        2_CD in_IN the_DT mouse_NN [_NN 5_CD 21_CD ]_NN ._. PGE_NNP 
        2_CD has_VBZ been_VBN reported_VBN to_TO stimulate_VB cAMP_NN
        formation_NN in_IN many_JJ tissues_NNS ,_, including_VBG intestine_NN ,_,
        microdissected_JJ renal_JJ tubule_NN segments_NNS ,_, and_CC uterus_NN via_IN
        butaprost_NN sensitive_JJ and_CC insensitive_JJ receptors_NNS [_NN 14_CD 26_CD 27_CD 28_CD
        29_CD ]_NN ._. The_DT mRNA_NN expression_NN results_NNS are_VBP consistent_JJ with_IN
        these_DT functional_JJ studies_NNS and_CC suggest_VBP that_IN the_DT EP_NNP 
        2_CD receptor_NN plays_VBZ important_JJ roles_NNS in_IN
        mediating_VBG PGE_NNP 2_CD stimulated_VBN cAMP_NN generation_NN in_IN these_DT tissues_NNS
        [_NN 14_CD 21_CD 26_CD 27_CD 28_CD 29_CD 30_CD 31_CD 32_CD 33_CD ]_NN ._.
        The_DT presence_NN of_IN the_DT rabbit_NN EP_NNP 
        2_CD receptor_NN mRNA_NN in_IN the_DT uterus_NN also_RB
        support_NN a_DT role_NN for_IN this_DT receptor_NN as_IN an_DT important_JJ mediator_NN
        of_IN PGE_NNP 
        2_CD action_NN in_IN this_DT organ_NN ._. This_DT is_VBZ in_IN
        agreement_NN with_IN previous_JJ studies_NNS which_WDT demonstrate_VBP that_IN EP_NNP 
        2_CD is_VBZ expressed_VBN and_CC highly_RB regulated_VBN in_IN
        uterine_NN luminal_NN epithelium_NN cells_NNS by_IN ovarian_NN steroids_NNS during_IN
        the_DT peri-implantation_JJ period_NN [_NN 5_CD 21_CD 34_CD 35_CD ]_NN ._. The_DT change_NN in_IN
        level_NN of_IN the_DT EP_NNP 
        2_CD receptor_NN expression_NN in_IN the_DT uterus_NN may_MD
        contribute_VB to_TO the_DT increase_NN in_IN G_NNP 
        S_NNP protein_NN content_NN and_CC cAMP_NN concentration_NN
        in_IN mid-gestation_JJ and_CC the_DT decrease_NN at_IN term_NN [_NN 26_CD 27_CD ]_NN ._.
        Because_IN the_DT EP_NNP 
        2_CD receptor_NN is_VBZ a_DT G_NNP 
        S_NNP -_: coupled_VBN cAMP-stimulating_JJ receptor_NN ,_,
        the_DT EP_NNP 
        2_CD receptor_NN may_MD participate_VB in_IN the_DT
        physiological_JJ regulation_NN of_IN uterine_NN relaxation_NN during_IN
        pregnancy_NN and_CC the_DT transition_NN into_IN uterine_NN contraction_NN at_IN
        the_DT onset_NN of_IN the_DT labor_NN ._. Lack_NN of_IN normal_JJ uterine_NN EP_NNP 
        2_CD expression_NN may_MD also_RB contribute_VB to_TO
        implantation_NN defect_NN reported_VBD in_IN EP_NNP 
        2_CD -_: /_NN -_: mice_NNS [_NN 8_CD 36_CD ]_NN ._.
        PGE_NNP 
        2_CD also_RB plays_VBZ a_DT critical_JJ role_NN in_IN
        regulating_VBG systemic_JJ blood_NN pressure_NN [_NN 37_CD 38_CD ]_NN ._. Although_IN the_DT
        receptor_NN mediating_VBG the_DT predominant_NN vasodilator_NN effect_NN of_IN
        PGE_NNP 
        2_CD remains_VBZ only_RB partially_RB defined_VBN ,_, recent_JJ
        gene_NN targeting_VBG studies_NNS suggest_VBP that_IN the_DT EP_NNP 
        2_CD receptor_NN may_MD be_VB an_DT important_JJ
        vasodilator_NN 
        in_IN vivo_NN [_NN 7_CD 8_CD ]_NN ._. The_DT rabbit_NN ear_NN
        artery_NN has_VBZ been_VBN used_VBN as_IN a_DT classic_JJ pharmacological_JJ model_NN of_IN
        an_DT EP_NNP 
        2_CD responsive_JJ tissue_NN ,_, while_IN the_DT rabbit_NN
        jugular_NN vein_NN has_VBZ been_VBN proposed_VBN to_TO be_VB an_DT EP_NNP 
        4_CD bearing_NN target_NN tissue_NN [_NN 3_CD 4_CD 39_CD ]_NN ,_,
        however_RB in_IN the_DT present_JJ studies_NNS EP_NNP 
        2_CD receptor_NN mRNA_NN was_VBD detected_VBN in_IN both_DT
        vessels_NNS ._. EP_NNP 
        2_CD mRNA_NN expression_NN was_VBD also_RB detected_VBN in_IN
        the_DT rabbit_NN aorta_NN and_CC inferior_JJ vena_NN cava_NN thus_RB providing_VBG
        further_JJ evidence_NN that_IN the_DT EP_NNP 
        2_CD receptor_NN is_VBZ functionally_RB expressed_VBN in_IN
        both_DT arteries_NNS and_CC veins_NNS ._. Expression_NNP of_IN this_DT G_NNP 
        S_NNP -_: coupled_VBN cAMP-stimulating_JJ PGE_NNP 
        2_CD receptor_NN in_IN cultured_JJ vascular_NN smooth_JJ
        muscle_NN cells_NNS isolated_VBN from_IN the_DT aorta_NN supports_VBZ a_DT direct_JJ role_NN
        of_IN the_DT EP_NNP 
        2_CD receptor_NN in_IN mediating_VBG vascular_NN
        relaxation_NN ._.
        PGE_NNP 
        2_CD has_VBZ also_RB been_VBN shown_VBN to_TO stimulate_VB cAMP_NN
        formation_NN in_IN several_JJ renal_JJ tissues_NNS ,_, notably_RB preglomerular_NN
        microvasculature_NN [_NN 14_CD ]_NN ,_, renal_JJ glomeruli_NN [_NN 40_CD ]_NN ,_, thin_JJ
        descending_VBG limb_NN [_NN 41_CD ]_NN ,_, medullary_JJ and_CC cortical_JJ thick_JJ
        ascending_VBG limb_NN ,_, and_CC collecting_VBG duct_NN [_NN 29_CD 42_CD ]_NN ._. Although_IN EP_NNP
        
        2_LS receptor_NN mRNA_NN expression_NN was_VBD detected_VBN
        in_IN the_DT kidney_NN and_CC this_DT was_VBD more_RBR pronounced_JJ in_IN the_DT renal_JJ
        cortex_NN than_IN in_IN the_DT medulla_NN ,_, no_DT specific_JJ regions_NNS of_IN EP_NNP 
        2_CD receptor_NN mRNA_NN expression_NN could_MD be_VB
        detected_VBN in_IN rabbit_NN kidney_NN by_IN 
        in_IN situ_NN hybridization_NN [_NN 19_CD ]_NN ._.
        Nonetheless_RB ,_, low_JJ levels_NNS of_IN EP_NNP 
        2_CD receptor_NN mRNA_NN expression_NN were_VBD detected_VBN
        by_IN RT-PCR_NNP or_CC RNase_NNP protection_NN assay_NN in_IN nephron_NN segments_NNS
        within_IN the_DT kidney_NN including_VBG preglomerular_NN vasculature_NN ,_,
        glomeruli_NN ,_, thin_JJ limbs_NNS of_IN Henle_NNP 's_POS loop_NN and_CC collecting_VBG ducts_NNS ._.
        The_DT expression_NN of_IN EP_NNP 2_CD receptor_NN mRNA_NN in_IN medullary_JJ collecting_NN
        duct_NN is_VBZ distinct_JJ from_IN functional_JJ studies_NNS in_IN the_DT cortical_JJ
        collecting_NN duct_NN where_WRB butaprost_NN had_VBD no_DT functional_JJ effect_NN [_NN
        17_CD 18_CD ]_NN ._. These_DT data_NNS suggest_VBP a_DT possible_JJ unique_JJ role_NN for_IN the_DT
        EP_NNP 2_CD receptor_NN in_IN the_DT medullary_JJ collecting_NN duct_NN as_IN opposed_VBN to_TO
        cortical_JJ collecting_NN duct_NN ._. Alternatively_RB the_DT PCR_NNP detection_NN
        of_IN EP_NNP 2_CD receptor_NN expression_NN in_IN these_DT microdissected_JJ segments_NNS
        might_MD result_VB from_IN the_DT adherent_NN renal_JJ interstitial_NN cells_NNS
        other_JJ than_IN collecting_VBG duct_NN itself_PRP ,_, since_IN nuclease_NN
        protection_NN analysis_NN revealed_VBD a_DT relatively_RB high_JJ EP_NNP 2_CD level_NN in_IN
        cultured_JJ intersitial_NN cells_NNS but_CC failed_VBD to_TO detect_VB EP_NNP 2_CD
        expression_NN in_IN cultured_JJ collecting_NN duct_NN cells_NNS ._. It_PRP is_VBZ notable_JJ
        that_DT glomeruli_NN and_CC collecting_VBG ducts_NNS are_VBP distinguished_VBN from_IN
        other_JJ segments_NNS by_IN high_JJ number_NN of_IN adherent_NN cells_NNS ._. Selective_NNP
        expression_NN of_IN the_DT EP_NNP 2_CD receptor_NN in_IN interstitial_NN cells_NNS is_VBZ
        consistent_JJ with_IN a_DT lack_NN of_IN segmental_NN localization_NN by_IN in_IN situ_NN
        hybridization_NN ._. Whether_IN the_DT EP_NNP 
        2_CD receptor_NN participates_VBZ in_IN PGE_NNP 
        2_CD stimulated_VBN cAMP_NN generation_NN in_IN
        epithelial_NN cells_NNS along_IN the_DT nephron_NN awaits_VBZ further_JJ
        investigation_NN [_NN 14_CD 42_CD ]_NN ._.
      
      
        Conclusions_NNP
        In_IN summary_NN ,_, we_PRP have_VBP cloned_VBN and_CC expressed_VBN a_DT butaprost_NN
        sensitive_JJ rabbit_NN PGE_NNP 2_CD receptor_NN that_IN stimulates_NNS cAMP_NN
        formation_NN and_CC is_VBZ present_JJ in_IN many_JJ rabbit_NN tissues_NNS ._.
        Physiological_NNP effects_NNS of_IN PGE_NNP 
        2_CD through_IN the_DT EP_NNP 
        2_CD receptor_NN may_MD mediate_VB important_JJ
        physiological_JJ actions_NNS in_IN these_DT tissues_NNS ._. EP_NNP 2_CD expression_NN in_IN
        uterus_NN ,_, vasculature_NN and_CC the_DT kidney_NN suggests_VBZ that_IN this_DT
        receptor_NN may_MD play_VB important_JJ roles_NNS in_IN the_DT functions_NNS of_IN
        reproductive_JJ system_NN ,_, vascular_NN tissues_NNS and_CC interstitium_NN of_IN
        the_DT kidney_NN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Ligands_NNP
          Unlabeled_NNP PGE_NNP 
          2_CD ,_, PGD_NNP 
          2_CD ,_, and_CC PGF_NNP 
          2_CD Î±_NN were_VBD purchased_VBN from_IN Cayman_NNP Chemical_NNP
          (_( Ann_NNP Arbor_NNP )_) ._. Butaprost_NNP free_JJ acid_NN was_VBD a_DT gift_NN from_IN Dr_NNP ._.
          Jilly_NNP Evans_NNP ,_, Merck-_NNP Frosst_NNP ._. Sulprostone_NNP ,_, misoprostol_NN ,_,
          iloprost_NN and_CC AH_NNP 13205_CD were_VBD kindly_RB provided_VBN by_IN Dr_NNP ._. Harold_NNP
          Kluender_NNP of_IN Miles_NNP Laboratories_NNPS ,_, P_NN ._. J_NNP ._. Gardiner_NNP of_IN Bayer_NNP
          UK_NNP ,_, Dr_NNP ._. Paul_NNP Collins_NNP of_IN G_NNP ._. D_NNP ._. Searle_NNP ,_, Dr_NNP ._. Rubanie_NNP of_IN
          Berlex_NNP Laboratories_NNPS and_CC Dr_NNP ._. R_NN ._. A_DT ._. Coleman_NNP of_IN Glaxo_NNP ,_, UK_NNP ,_,
          respectively_RB ._. [_NN 3_CD H_NNP ]_NN PGE_NNP 
          2_CD was_VBD purchased_VBN from_IN Dupont_NNP NEN_NNP ._.
        
        
          Rabbit_NNP genomic_JJ library_NN screening_NN
          A_DT rabbit_NN genomic_JJ library_NN in_IN Lamda_NNP DASH_NNP Â®_NN II_NNP vector_NN
          (_( Stratagene_NNP )_) was_VBD screened_VBD with_IN [_NN 32_CD P_NN ]_NN -_: labeled_VBN full-length_JJ
          human_JJ EP_NNP 
          2_CD (_( gift_NN from_IN Dr_NNP ._. D_NNP ._. Woodward_NNP ,_, Allergan_NNP
          Pharmaceuticals_NNP )_) [_NN 20_CD ]_NN ._. The_DT filters_NNS were_VBD fixed_VBN by_IN
          ultraviolet_NN light_JJ exposure_NN (_( Stratalinker_NNP ,_, Stratagene_NNP )_) and_CC
          hybridized_JJ 18_CD hours_NNS at_IN 56_CD Â°_NN C_NNP in_IN a_DT solution_NN containing_VBG 6_CD X_NNP
          SSC_NNP ,_, 5_CD X_NNP Denhardt_NNP 's_POS ,_, 0_CD ._. 1_CD %_NN SDS_NNP ,_, 150_CD Î¼g_NN /_NN ml_NN denatured_JJ herring_NN
          sperm_NN DNA_NNP and_CC 3_CD Ã—_NN 10_CD 6_CD cpm_NN /_NN ml_NN labeled_VBD probe_NN ._. Two_CD
          representative_NN positive_JJ clones_NNS ,_, 4_CD B_NNP and_CC 6_CD A_DT ,_, were_VBD isolated_VBN
          from_IN 5_CD Ã—_NN 10_CD 5_CD recombinant_JJ plaques_NNS and_CC shown_VBN to_TO exhibit_VB
          unique_JJ restriction_NN patterns_NNS ._. A_DT XbaI_NNP /_NN NotI_NNP fragment_NN from_IN
          clone_NN 4_CD B_NNP 1_CD and_CC a_DT NotI_NNP fragment_NN from_IN 6_CD A_DT 1_CD hybridized_JJ to_TO the_DT
          probe_NN and_CC were_VBD subcloned_JJ in_IN pBluesript_NN II_NNP SK_NNP (_( -_: )_)
          (_( Stratagene_NNP )_) for_IN further_JJ analysis_NN ._.
        
        
          cDNA_NN cloning_VBG
          A_DT rabbit_NN uterus_NN cDNA_NN library_NN in_IN ZAP_NNP II_NNP (_( Stratagene_NNP )_) (_( a_DT
          gift_NN from_IN Dr_NNP ._. J_NNP ._. Lytton_NNP ,_, Harvard_NNP Medical_NNP School_NNP )_) was_VBD
          screened_VBD using_VBG an_DT AvaII_NNP cDNA_NN fragment_NN of_IN 750_CD bp_NN from_IN the_DT
          genomic_JJ clone_NN 4_CD B_NNP 1_CD ._. 10_CD 6_CD plaques_NNS were_VBD probed_JJ under_IN high_JJ
          stringency_NN ,_, and_CC 18_CD positive_JJ plaques_NNS were_VBD purified_JJ ._. The_DT
          isolated_VBN cDNA-bearing_JJ phages_NNS were_VBD rescued_VBD to_TO plasmids_NNS
          according_VBG to_TO the_DT manufacturer_NN 's_POS instruction_NN ._. Clones_NNP were_VBD
          analyzed_VBN by_IN restriction_NN digestion_NN ,_, and_CC nucleotide_NN
          sequencing_VBG was_VBD carried_VBN out_IN on_IN both_DT strands_NNS by_IN the_DT dideoxy_NN
          chain_NN termination_NN method_NN ._.
        
        
          Construction_NNP of_IN an_DT open_JJ reading_NN frame_NN of_IN EP_NNP 2_CD and_CC
          its_PRP$ expression_NN in_IN COS-_NNP 1_CD cells_NNS
          One_CD 5_CD '_POS truncated_JJ cDNA_NN clone_NN ,_, REP_NNP 2_CD -_: 18_CD A_DT ,_, was_VBD highly_RB
          homologous_RB to_TO the_DT human_JJ EP_NNP 
          2_CD receptor_NN but_CC lacked_VBD the_DT 5_CD '_POS 150_CD bp_NN
          encoding_VBG the_DT first_JJ 50_CD amino_JJ acids_NNS (_( see_VB results_NNS )_) ._. REP_NNP 2_CD -_: 18_CD A_DT
          was_VBD digested_VBN by_IN Sac_NNP II_NNP /_NN Xho_NNP I_PRP ,_, and_CC the_DT 3_CD '_POS restriction_NN
          fragment_NN (_( 1_CD ,_, 312_CD bp_NN )_) was_VBD ligated_JJ to_TO the_DT Sac_NNP II_NNP /_NN Hind_NNP III_NNP
          fragment_NN (_( 350_CD bp_NN )_) of_IN the_DT 4_CD B_NNP 1_CD genomic_JJ clone_NN at_IN the_DT Sac_NNP II_NNP
          site_NN ._. This_DT resulted_VBD in_IN a_DT 1_CD ._. 7_CD kb_NN fragment_NN ,_, YZ_NNP 4_CD ,_, containing_VBG
          a_DT putative_JJ open_JJ reading_NN frame_NN ._. YZ_NNP 4_CD was_VBD then_RB subcloned_JJ
          into_IN the_DT eukaryotic_JJ expression_NN vector_NN pcDNA_NN 3_CD (_( Invitrogen_NNP )_)
          and_CC the_DT resultant_JJ plasmid_NN ,_, pcDNA_NN 3_CD /_NN REP_NNP 
          2_CD ,_, was_VBD transfected_JJ into_IN COS-_NNP 1_CD using_VBG
          lipofectamine_NN according_VBG to_TO the_DT manufacturer_NN 's_POS directions_NNS
          (_( Life_NNP Science_NNP Technologies_NNPS )_) with_IN 12_CD Î¼g_NN plasmid_NN DNA_NNP and_CC 45_CD
          Î¼L_NN lipofectamine_NN solution_NN ._. Cells_NNP were_VBD cultured_JJ for_IN 72_CD
          hours_NNS ,_, and_CC 5_CD mM_NN sodium_NN butyrate_NN was_VBD added_VBN to_TO culture_NN
          medium_NN 16_CD hours_NNS before_IN lysis_NNS ._. Total_JJ cell_NN membranes_NNS were_VBD
          prepared_VBN as_IN described_VBN previously_RB [_NN 23_CD ]_NN ._.
        
        
          Ligand_NNP binding_JJ analysis_NN
          Saturation_NNP isotherm_NN ligand_NN binding_JJ experiments_NNS were_VBD
          performed_VBN using_VBG 15_CD -_: 20_CD Î¼g_NN of_IN membrane_NN protein_NN incubated_JJ
          with_IN increasing_VBG concentrations_NNS of_IN [_NN 3_CD H_NNP ]_NN PGE_NNP 
          2_CD at_IN 30_CD Â°_NN C_NNP for_IN 2_CD hours_NNS ,_, in_IN binding_JJ
          buffer_NN (_( 25_CD mM_NN KPO_NNP 
          4_CD ,_, pH_NN 6_CD ._. 2_LS ,_, 10_CD mM_NN MgCl_NNP 
          2_CD ,_, and_CC 1_CD mM_NN EDTA_NNP )_) ._. The_DT reaction_NN was_VBD
          stopped_VBN by_IN adding_VBG 1_CD ml_NN of_IN ice-cold_JJ binding_JJ buffer_NN
          followed_VBN by_IN rapid_JJ filtration_NN on_IN Inotech_NNP IH-_NNP 201_CD -_: A_DT 21_CD glass_NN
          fiber_NN filters_NNS employing_VBG an_DT Inotech_NNP 96_CD well_RB filtration_NN
          manifold_NN (_( Inotech_NNP Biosystems_NNP ,_, Lansing_NNP ,_, MI_NNP )_) ._. Filters_NNP then_RB
          were_VBD washed_VBN 3_CD times_NNS with_IN binding_JJ buffer_NN ,_, dried_VBD briefly_NN
          and_CC counted_VBN in_IN a_DT Beckman_NNP LS_NNP 6500_CD multi-purpose_JJ
          scintillation_NN counter_NN ._. Nonspecific_NNP binding_JJ was_VBD defined_VBN as_IN
          the_DT radioactivity_NN remaining_VBG bound_VBN to_TO the_DT filter_NN in_IN the_DT
          presence_NN of_IN 50_CD Î¼M_NN unlabelled_JJ PGE_NNP 
          2_CD ._. For_IN competition_NN binding_JJ assays_NNS ,_, 20_CD
          Î¼g_NN of_IN membrane_NN protein_NN was_VBD incubated_JJ with_IN 1_CD nM_NN [_NN 3_CD H_NNP ]_NN PGE_NNP 
          2_CD and_CC varying_VBG concentrations_NNS of_IN
          unlabeled_JJ competitors_NNS ._. Reactions_NNP were_VBD carried_VBN out_IN as_IN
          above_IN ._.
        
        
          cAMP_NN measurements_NNS
          COS_NNP 1_CD cells_NNS were_VBD transiently_RB transfected_JJ with_IN the_DT EP_NNP 
          2_CD receptor_NN expression_NN plasmid_NN were_VBD
          distributed_VBN onto_IN 24_CD -_: well_RB plates_NNS ._. The_DT medium_NN was_VBD replaced_VBN
          24_CD hours_NNS later_RB and_CC incubated_JJ one_CD additional_JJ hour_NN at_IN 37_CD Â°_NN C_NNP
          in_IN 450_CD Î¼L_NN DMEM_NNP plus_CC 0_CD ._. 25_CD mM_NN 3_CD -_: isobutyl-_NN 1_CD -_: methylxanthine_NN
          (_( IBMX_NNP )_) ,_, and_CC 40_CD mM_NN indomethacin_NN ._. Following_VBG this_DT medium_NN
          containing_VBG varying_VBG amounts_NNS of_IN butaprost_NN free_JJ acid_NN was_VBD
          added_VBN to_TO each_DT well_RB for_IN 5_CD minutes_NNS ._. The_DT reactions_NNS were_VBD
          stopped_VBN by_IN addition_NN of_IN 500_CD Î¼L_NN of_IN 10_CD %_NN trichloroacetic_JJ
          acid_NN ._. cAMP_NN measurement_NN of_IN the_DT cell_NN lysates_NNS were_VBD performed_VBN
          by_IN an_DT EIA_NNP according_VBG to_TO manufacturer_NN 's_POS instructions_NNS
          (_( Stratagene_NNP )_) ._.
        
        
          Isolation_NNP of_IN renal_JJ microvessels_NNS and_CC dissection_NN of_IN
          nephron_NN segments_NNS
          Renal_NNP preglomerular_NN microvessels_NNS were_VBD isolated_VBN
          according_VBG to_TO a_DT protocol_NN from_IN Chaudhari_NNP and_CC Kirschenbaum_NNP [_NN
          43_CD ]_NN ._. Briefly_NNP ,_, in_IN anesthetized_JJ animals_NNS kidneys_NNS were_VBD
          exposed_VBN and_CC the_DT renal_JJ artery_NN cannulated_JJ ._. The_DT kidneys_NNS were_VBD
          perfused_JJ with_IN 10_CD ml_NN of_IN ice_NN cold_JJ normal_JJ saline_NN ,_, followed_VBN
          by_IN 10_CD ml_NN of_IN a_DT 1_CD %_NN suspension_NN of_IN magnetized_VBN iron_NN oxide_NN (_( Fe_NNP 
          3_CD O_NNP 
          4_CD ,_, Aldrich_NNP )_) in_IN normal_JJ saline_NN ._. The_DT
          cortex_NN of_IN the_DT kidneys_NNS was_VBD minced_JJ with_IN a_DT tissue_NN press_NN and_CC
          homogenized_JJ using_VBG a_DT Polytron_NNP homogenizer_NN at_IN moderate_JJ
          speed_NN for_IN 15_CD s_VBZ Ã—_NN 2_CD ._. Microvessels_NNP were_VBD separated_JJ from_IN
          nonvascular_NN tissue_NN in_IN several_JJ washing_NN steps_NNS (_( in_IN 1_CD Ã—_NN PBS_NNP )_)
          utilizing_VBG a_DT strong_JJ magnet_NN field_NN ._. Washing_NNP and_CC separation_NN
          were_VBD repeated_VBN after_IN passing_VBG the_DT homogenate_NN through_IN 20_CD -_: ,_,
          21_CD -_: and_CC 23_CD -_: gauge_VB needles_NNS ,_, respectively_RB ,_, until_IN the_DT
          suspension_NN was_VBD mostly_RB free_JJ of_IN glomeruli_NN and_CC other_JJ
          nonvascular_NN tissue_NN ._. This_DT technique_NN provided_VBD a_DT large_JJ
          quantity_NN of_IN relatively_RB pure_JJ preglomerular_NN microvessels_NNS ,_,
          with_IN approximately_RB 10_CD -_: 15_CD %_NN of_IN the_DT suspension_NN consisting_VBG
          of_IN attached_VBN glomeruli_NN and_CC early_JJ segments_NNS of_IN proximal_NN
          tubules_NNS ._. Microdissection_NNP of_IN nephron_NN segments_NNS was_VBD
          performed_VBN in_IN the_DT kidney_NN of_IN New_NNP Zealand_NNP White_NNP rabbit_NN as_RB
          previously_RB described_VBD [_NN 44_CD ]_NN ._. The_DT following_VBG segments_NNS were_VBD
          dissected_VBN :_: glomeruli_NN ,_, proximal_NN convoluted_JJ tubules_NNS (_( PCT_NNP )_) ,_,
          proximal_NN straight_JJ tubules_NNS (_( PST_NNP )_) ,_, thin_JJ limbs_NNS of_IN Henle_NNP 's_POS
          loop_NN (_( tDL_NN /_NN tAL_NN )_) ,_, thick_JJ ascending_VBG limb_NN (_( TAL_NNP )_) ,_, distal_NN
          convoluted_JJ tubules_NNS (_( DCT_NNP )_) ,_, cortical_JJ collecting_NN ducts_NNS (_( CCD_NNP )_)
          and_CC medullary_JJ collecting_NN duct_NN (_( MCD_NNP )_) cells_NNS ._.
        
        
          PCR_NNP ampification_NN of_IN Rabbit_NNP EP_NNP 2_CD receptor_NN
          Fragment_NNP
          Total_NNP RNA_NNP was_VBD purified_JJ from_IN dissected_VBN nephron_NN segments_NNS
          using_VBG Tri_NNP Reagent_NNP (_( Molecular_NNP Research_NNP Center_NNP )_) and_CC
          reverse-transcribed_JJ to_TO single-stranded_JJ cDNA_NN using_VBG Moloney_NNP
          murine_NN leukemia_NN virus_NN reverse_NN transcriptase_NN and_CC 2_CD ._. 5_CD Î¼M_NN of_IN
          random_JJ hexamers_NNS according_VBG to_TO the_DT manufacturer_NN 's_POS protocol_NN
          (_( GeneAmp_NNP RNA_NNP PCR_NNP kit_NN ,_, Perkin_NNP Elmer_NNP Cetus_NNP ,_, Norwalk_NNP ,_, CT_NNP )_) ._.
          The_DT cDNAs_NNS were_VBD then_RB amplified_VBN using_VBG EP_NNP 2_CD and_CC GAPDH_NNP
          selective_JJ primers_NNS ._. Primers_NNP were_VBD selected_VBN from_IN rabbit_NN cDNA_NN
          sequences_NNS ._. For_IN rabbit_NN EP_NNP 2_CD :_: 5_CD '_POS -_: TCC_NNP TCC_NNP CGA_NNP AAA_NNP GAA_NNP AAG_NNP
          TGG-_NNP 3_CD '_POS for_IN sense_NN and_CC 5_CD '_POS -_: TGT_NNP TTA_NNP CCC_NNP CGT_NNP TTT_NNP ATC_NNP AGG-_NNP 3_CD '_POS
          for_IN antisense_NN ;_: for_IN rabbit_NN GAPDH_NNP :_: 5_CD '_POS -_: CGG_NNP AGC_NNP CAA_NNP AAG_NNP GGT_NNP
          CAT_NNP CAT-_NNP 3_CD '_POS for_IN sense_NN and_CC 5_CD '_POS -_: TTT_NNP CTC_NNP CAG_NNP GCG_NNP GCA_NNP GGT_NNP
          CAG-_NNP 3_CD '_POS for_IN antisense_NN ._. These_DT primers_NNS were_VBD used_VBN to_TO amplify_VB
          a_DT 336_CD bp_NN of_IN EP_NNP 2_CD cDNA_NN fragment_NN and_CC 411_CD bp_NN of_IN GAPDH_NNP cDNA_NN
          fragment_NN ._. PCR_NNP reactions_NNS were_VBD carried_VBN out_IN in_IN 10_CD mM_NN
          Tris-_NNP HCl_NNP (_( pH_NN 8_CD ._. 3_LS )_) ,_, 50_CD mM_NN KCl_NNP ,_, 2_CD ._. 5_CD mM_NN MgCl_NNP 
          2_CD ,_, 0_CD ._. 2_CD mM_NN dNTPs_NNS and_CC 1_CD Î¼M_NN primers_NNS at_IN
          94_CD Â°_NN C_NNP for_IN 0_CD ._. 5_CD min_NN ,_, 60_CD Â°_NN C_NNP for_IN 0_CD ._. 5_CD min_NN ,_, and_CC 72_CD Â°_NN C_NNP for_IN 1_CD ._. 0_CD min_NN
          for_IN 35_CD cycles_NNS in_IN a_DT Perkin_NNP Elmer_NNP Cetus_NNP 9600_CD thermal_JJ
          cycler_NN ._. PCR_NNP products_NNS were_VBD separated_VBN by_IN 1_CD %_NN agarose_NN gel_NN and_CC
          further_RBR confirmed_VBN by_IN Southern_NNP hybridization_NN and_CC
          sequencing_VBG ._.
        
        
          Culture_NNP of_IN rabbit_NN aortic_JJ smooth_JJ muscle_NN cells_NNS
          (_( VSMCs_NNP )_) ,_, cortical_JJ collecting_NN duct_NN cells_NNS (_( CCD_NNP )_) ,_, glomerular_NN
          mesangial_NN cells_NNS (_( MCs_NNP )_) and_CC renal_JJ medullary_JJ interstitial_NN
          cells_NNS (_( MICs_NNP )_)
          The_DT aorta_NN was_VBD cut_VBN open_JJ in_IN a_DT longitudinal_NN section_NN and_CC
          the_DT thin_JJ layer_NN of_IN endothelial_NN cells_NNS was_VBD removed_VBN using_VBG a_DT
          cotton-tipped_JJ applicator_NN ._. The_DT aorta_NN was_VBD cut_VBN into_IN small_JJ
          pieces_NNS and_CC suspended_VBN in_IN DMEM_NNP medium_NN containing_VBG 20_CD %_NN FCS_NNP
          and_CC grown_VBN in_IN a_DT culture_NN dish_NN in_IN standard_JJ incubation_NN at_IN
          37_CD Â°_NN C_NNP ._. One_CD week_NN later_RB ,_, the_DT VSMCs_NNP had_VBD outgrown_VBN from_IN the_DT
          tissue_NN suspension_NN ,_, and_CC were_VBD transferred_VBN to_TO a_DT new_JJ flask_NN ._.
          The_DT medium_NN was_VBD changed_VBN every_DT other_JJ day_NN ,_, the_DT identity_NN of_IN
          the_DT VSMCs_NNP was_VBD confirmed_VBN by_IN Î±-actin_JJ fluorescence_NN staining_VBG
          as_IN described_VBN [_NN 45_CD ]_NN ._. Glomerular_NNP MCs_NNP ,_, CCD_NNP cells_NNS and_CC MICs_NNP
          were_VBD cultured_JJ as_IN we_PRP previously_RB reported_VBD [_NN 22_CD 44_CD 46_CD ]_NN
          ._.
        
        
          Solution_NN hybridization_NN /_NN RNase_NNP protection_NN
          assays_NNS
          RNase_NNP protection_NN assays_NNS were_VBD performed_VBN as_IN described_VBN
          previously_RB [_NN 22_CD ]_NN ._. A_DT Hind_NNP III_NNP fragment_NN of_IN the_DT rabbit_NN EP_NNP 
          2_CD receptor_NN located_VBN in_IN the_DT the_DT 3_CD '_POS
          untranslated_JJ region_NN (_( 3_CD '_POS UTR_NNP )_) was_VBD subcloned_JJ into_IN
          pBluescript_NN SK_NNP (_( -_: )_) plasmid_NN (_( Stratagene_NNP )_) ._. Plasmids_NNP
          containing_VBG rabbit_NN EP_NNP 
          1_CD (_( 250_CD bp_NN )_) [_NN 22_CD ]_NN EP_NNP 
          2_CD (_( 322_CD bp_NN )_) ,_, EP_NNP 
          3_CD (_( 466_CD bp_NN )_) [_NN 24_CD ]_NN and_CC EP_NNP 
          4_CD (_( 328_CD bp_NN )_) [_NN 23_CD ]_NN were_VBD used_VBN to_TO
          synthesize_VB cRNA_NN probes_NNS for_IN solution_NN hybridization_NN of_IN
          total_JJ RNA_NNP from_IN various_JJ tissues_NNS ._. Briefly_NNP ,_, the_DT fragments_NNS of_IN
          EP_NNP 
          1_CD ,_, EP_NNP 
          2_CD ,_, EP_NNP 
          3_CD and_CC EP_NNP 
          4_CD cDNA_NN were_VBD subcloned_JJ in_IN pBluscript_NN
          SK_NNP (_( -_: )_) vector_NN ,_, and_CC the_DT antisense_NN orientation_NN was_VBD
          determined_VBN by_IN dideoxy-_NN DNA_NNP sequencing_VBG ._. Radiolabeled_NNP
          riboprobes_NNS were_VBD synthesized_JJ from_IN linearized_JJ plasmid_NN DNA_NNP
          (_( 1_CD Î¼g_NN )_) transcribed_JJ in_IN vitro_NN with_IN 10_CD U_NNP of_IN T_NN 3_CD RNA_NNP
          polymerase_NN by_IN using_VBG MAXIscript_NNP â„¢_NN kit_NN (_( Ambion_NNP )_) for_IN 1_CD hour_NN
          at_IN 37_CD Â°_NN C_NNP in_IN a_DT total_JJ reaction_NN volume_NN of_IN 20_CD Î¼l_NN ._. The_DT reaction_NN
          buffer_NN contained_VBD 10_CD mM_NN dithiothreitol_NN (_( DTT_NNP )_) ,_, 0_CD ._. 5_CD Î¼M_NN of_IN
          ATP_NNP ,_, CTP_NNP ,_, and_CC GTP_NNP ,_, 2_CD ._. 5_CD Î¼M_NN of_IN UTP_NNP ,_, and_CC 5_CD Î¼l_NN of_IN 800_CD Ci_NNP /_NN mmol_NN
          [_NN Î±-_NN 32_CD P_NN ]_NN UTP_NNP at_IN 10_CD mCi_NN /_NN ml_NN (_( Dupont_NNP NEN_NNP )_) ._. Hybridization_NNP
          buffer_NN included_VBD 80_CD %_NN deionized_JJ formamide_NN ,_, 100_CD mM_NN sodium_NN
          citrate_NN ,_, pH_NN 6_CD ._. 4_LS ,_, 300_CD mM_NN sodium_NN acetate_NN ,_, pH_NN 6_CD ._. 4_LS and_CC 1_CD mM_NN
          EDTA_NNP (_( RPAII_NNP ,_, Ambion_NNP )_) ._. Twenty_CD micrograms_NNS of_IN total_JJ RNAs_NNP
          from_IN rabbit_NN tissues_NNS ,_, preglomerular_NN vessels_NNS ,_, cultured_JJ
          cells_NNS were_VBD incubated_JJ at_IN 45_CD Â°_NN C_NNP overnight_JJ in_IN hybridization_NN
          buffer_NN with_IN 1_CD Ã—_NN 10_CD 5_CD cpm_NN labeled_VBD riboprobe_NN ._. After_IN
          hybridization_NN ,_, ribonuclease_NN digestion_NN (_( 20_CD mg_NN /_NN ml_NN )_) was_VBD
          carried_VBN out_RB at_IN 37_CD Â°_NN C_NNP for_IN 30_CD minutes_NNS ._. Precipitated_NNP
          protected_VBD fragments_NNS were_VBD separated_JJ on_IN a_DT 4_CD %_NN polyacrylamide_NN
          gel_NN at_IN 200_CD V_NNP for_IN 3_CD ._. 5_CD hours_NNS ._. End-labeled_NNP 100_CD bp_NN DNA_NNP
          markers_NNS were_VBD used_VBN as_IN molecular_JJ weight_NN standards_NNS
          (_( Promega_NNP )_) ._. The_DT gel_NN was_VBD exposed_VBN to_TO Kodak_NNP XAR-_NNP 5_CD film_NN
          overnight_JJ at_IN -_: 80_CD Â°_NN C_NNP ,_, with_IN intensifying_VBG screens_NNS ._.
        
        
          In_IN situ_NN hybridization_NN
          
          In_IN situ_NN hybridization_NN was_VBD performed_VBN
          as_RB previously_RB described_VBD [_NN 22_CD ]_NN ._. Rabbit_NNP uterus_NN and_CC kidney_NN
          were_VBD fixed_VBN in_IN 4_CD %_NN paraformaldehyde_NN ,_, and_CC embedded_VBN in_IN
          paraffin_NN ._. Seven_CD Î¼m_NN sections_NNS were_VBD cut_VBN and_CC hybridized_JJ with_IN
          [_NN 35_CD S_NNP ]_NN -_: labeled_VBN riboprobe_NN used_VBN in_IN the_DT RNase_NNP protection_NN
          assays_NNS at_IN 55_CD Â°_NN C_NNP for_IN 18_CD hours_NNS ._. Following_VBG hybridization_NN ,_,
          sections_NNS were_VBD washed_VBN at_IN 50_CD Â°_NN C_NNP in_IN 50_CD %_NN formamide_NN ,_, 2_CD X_NNP SSC_NNP ,_,
          and_CC 100_CD mM_NN Î²-mercaptoethanol_JJ for_IN 60_CD minutes_NNS ._. Sections_NNP
          were_VBD treated_VBN with_IN RNase_NNP A_DT (_( 10_CD Î¼g_NN /_NN ml_NN )_) at_IN 37_CD Â°_NN C_NNP for_IN 30_CD
          minutes_NNS ,_, followed_VBN by_IN washes_NNS in_IN 10_CD mM_NN Tris_NNP ,_, 5_CD mM_NN EDTA_NNP ,_, 500_CD
          mM_NN NaCl_NNP at_IN 37_CD Â°_NN C_NNP ;_: 2_CD X_NNP SSC_NNP at_IN 50_CD Â°_NN C_NNP ;_: and_CC 0_CD ._. 1_CD X_NNP SSC_NNP at_IN 50_CD Â°_NN C_NNP ._.
          Slides_NNS were_VBD dehydrated_JJ with_IN ethanol_NN containing_VBG 300_CD mM_NN
          ammonium_NN acetate_NN ._. Photomicrographs_NNP were_VBD taken_VBN from_IN slides_NNS
          dipped_VBD in_IN emulsion_NN (_( Ilford_NNP K_NNP 5_CD ,_, Knutsford_NNP ,_, Cheshire_NNP ,_,
          England_NNP )_) diluted_VBN 1_CD :_: 1_CD with_IN 2_CD %_NN glycerol_NN and_CC exposed_VBN for_IN 7_CD
          days_NNS at_IN 4_CD Â°_NN C_NNP ._. After_IN developing_VBG in_IN Kodak_NNP D-_NNP 19_CD ,_, slides_NNS were_VBD
          counterstained_JJ with_IN hematoxylin_NN and_CC eosin_NN ._.
          Photomicrographs_NNP were_VBD taken_VBN by_IN a_DT Zeiss_NNP Axioskop_NNP
          microscope_NN using_VBG dark-field_JJ optics_NNS ._.
        
        
          Data_NNP analysis_NN
          All_DT binding_JJ assays_NNS and_CC cAMP_NN measurements_NNS were_VBD plotted_VBD
          using_VBG PRISM_NNP (_( GraphPad_NNP ,_, San_NNP Diego_NNP ,_, CA_NNP )_) ._.
        
      
      
        Authors_NNP '_'' contributions_NNS
        YG_NNP carried_VBD out_RP the_DT molecular_JJ cloning_VBG studies_NNS ,_,
        participated_VBD in_IN the_DT sequence_NN alignment_NN and_CC drafted_VBD the_DT
        manuscript_NN ._. BAS_NNP carried_VBD out_RP the_DT cAMP_NN assays_NNS ._. YZ_NNP
        participated_VBD in_IN examining_VBG tissue_NN distribution_NN of_IN EP_NNP 2_CD
        receptor_NN ._. AS_NNP participated_VBD in_IN preparation_NN of_IN preglomeruli_NN ,_,
        OS_NNP carried_VBD out_RP the_DT nephron_NN dissection_NN ._. LSD_NNP did_VBD the_DT in_IN situ_NN
        hybridization_NN ._. RR_NNP participated_VBD in_IN dissecting_VBG nephron_NN
        segments_NNS ._. RMB_NNP and_CC MDB_NNP supervised_VBD the_DT design_NN of_IN the_DT
        study_NN ._.
      
      
        Abbreviations_NNP
        Prostaglandin_NNP E_NNP 
        2_CD (_( PGE_NNP 
        2_LS )_) ;_: cortical_JJ thick_JJ ascending_VBG limb_NN
        (_( cTAL_NN )_) ;_: thin_JJ descending_VBG limb_NN of_IN Henle_NNP 's_POS loop_NN (_( tDL_NN )_) ;_:
        cortical_JJ and_CC outer_JJ medullary_JJ collecting_NN ducts_NNS (_( CCD_NNP ,_, OMCD_NNP )_) ;_:
        reverse_VB transcription-polymerase_JJ chain_NN reaction_NN
        (_( RT-PCR_NNP )_)
      
    
  
